Post by Claudio J. Alarcón C.

I am pleased to share our recent publication in Frontiers in Pharmacology, focused on pharmacogenomics and treatment-related toxicity in pediatric acute lymphoblastic leukemia. This work contributes to the generation of local evidence to support the future implementation of personalized medicine in Latin America. Understanding why some patients are more susceptible to treatment toxicity is a key step toward safer and more individualized cancer care. Muy contento de compartir este trabajo, que busca aportar evidencia desde Latinoamérica para avanzar hacia una medicina más personalizada, segura y contextualizada para nuestros pacientes. Grateful to Matías Martínez Olguín Carolina Gutiérrez Cáceres Leslie Cerpa Javiera A. and all collaborators involved in this project. Article available here: https://lnkd.in/eN35XCUA #Pharmacogenomics #PersonalizedMedicine #PrecisionMedicine #PediatricOncology #LatinAmerica #ClinicalPharmacology